Dr. Allan Marc Conway, MD

Dr. Conway practices at Endoscopy Center of Marin - HOPD in Greenbrae, California.

Dr. Conway's NPI, 1003100025, was assigned on June 7, 2011. Dr. Conway graduated from University of Manchester Faculty of Medicine in 2007. Dr. Conway holds California license C181243.

Dr. Conway's primary practice is Endoscopy Center of Marin - HOPD, at 1100 S Eliseo Dr, Greenbrae, CA 94904.

Dr. Conway's primary practice is Endoscopy Center of Marin - HOPD in Greenbrae, California. Dr. Conway is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Conway to 2 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conway practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Conway's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Conway is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Conway's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Conway treats.

CMS data shows 1,222 Medicare services from Dr. Conway across 21 procedure codes in 2024, for 715 Medicare patients. Medicare paid $78,129 for them.

CMS counts 715 Medicare patients who saw Dr. Conway in 2024. The largest group is 75 to 84, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conway's median patient age at 74, with 46% women.

In 2024, Dr. Conway wrote 30 Medicare Part D claims for 13 patients. 60% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $82 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Conway for performance year 2024. CMS lists Dr. Conway as offering telehealth. CMS counts 12 procedures of varicose vein removal by Dr. Conway, more than 46% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 50 papers to Dr. Conway, published from 2008 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Vascular Surgical Procedures. Dr. Conway has published most often in Ann Vasc Surg. Dr. Conway's most frequent co-authors are Gary Giangola, MD, Alfio Carroccio, MD and Karl Y. Bilimoria, MD.

CMS Open Payments shows 219 general payments to Dr. Conway from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. MAQUET Cardiovascular U.S. Sales, L.L.C. paid the most, $12,322.

Dr. Conway graduated from University of Manchester Faculty of Medicine in 2007.

Dr. Conway is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.